Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Says PCR Products Boost Q3 Life Science Sales


Bio-Rad Laboratories this week reported a 2 percent increase in its third-quarter revenues, to $471.5 million from $461.1 million in the comparable period of 2009.

Sales for the company's life science segment increased 2 percent to $153.2 million, while clinical diagnostics sales were also up around 2 percent to $314.9 million. Clinical diagnostic sales include $13.6 million from the Biotest business, which Bio-Rad acquired in the first quarter of 2010.

The company said in a statement that the life science segment "benefited from strong sales of core product lines," including its next-generation CFX96 real-time PCR detection system and associated reagents.

Bio-Rad posted net income of $44.8 million, or $1.59 per share, versus net income of $38.5 million, or $1.38 per share, for the prior-year period.

Third-quarter R&D spending increased around 9 percent to $42.9 million from $39.5 million, while SG&A expenses fell 3 percent to $148.7 million from $153.6 million.

Bio-Rad finished the quarter with $630.6 million in cash and cash equivalents and $107.4 million in short-term investments.

The firm expects organic revenue growth for full-year 2010 to be in the 4 percent to 5 percent range. The company expects to report fourth-quarter sales of between $510 million and $520 million.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.